PDS Releases First Publicly Available, FDA-Validated Dataset for SEND
News May 20, 2014
“PDS is committed to making significant contributions to electronic standards use and development in the noncompetitive space”
PDS is the developer of TranSEND™, a complete platform-agnostic, Web-based software solution for aggregating and integrating data from multiple laboratory information management systems (LIMS) into SEND-compliant datasets for FDA submission. The dataset can be used by scientists and research organizations across the industry to aid in validation and to serve as an example of a complete and FDA-compliant SEND dataset. PDS has released this anonymized dataset to demonstrate its commitment to advancing the use of data standards.
“PDS is committed to making significant contributions to electronic standards use and development in the noncompetitive space,” said Laura Kaufman, Ph.D., DABT, director of Preclinical Affairs for PDS. “Conformance with FDA validation requirements is mission critical for FDA acceptance and review of SEND submissions.”
PDS posted a link to the dataset on the Pharmaceutical Users Software Exchange (PhUSE) website for use by the community.
Sysmex Partners with Laboratories to Deliver Improved QC ManagementNews
Sysmex America has announced its latest innovation: a way to make quality assurance easier and more risk free than manual quality control processes.READ MORE
BMS, QIAGEN Partner to Develop Gene Expression Profiles for Immuno-OncologyNews
QIAGEN and Bristol-Myers Squibb intend to develop GEPs for several Bristol-Myers Squibb I-O molecules under the initial agreement.READ MORE
Comments | 0 ADD COMMENT
EMBL Course: Introduction to Next Generation Sequencing
Apr 09 - Apr 12, 2018
EMBL Course: RNA Sequencing Library Preparation - How Low Can You Go?
Mar 19 - Mar 23, 2018
EMBL Course: Analysis and Integration of Transcriptome and Proteome Data
Mar 12 - Mar 16, 2018
EMBO | EMBL Symposium: Tissue Self-Organisation: Challenging the Systems
Mar 11 - Mar 14, 2018